Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biocad CJSC
DescriptionHumanized mAb targeting IL-17
Molecular Target Interleukin-17 (IL-17)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationPsoriasis
Indication DetailsTreat moderate to severe plaque psoriasis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today